| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |